- Home
- ASYS vs HLVX Comparison
ASYS vs HLVX Comparison
Compare ASYS & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- HLVX
- Stock Information
- Founded
- ASYS 1981
- HLVX 2020
- Country
- ASYS United States
- HLVX United States
- Employees
- ASYS N/A
- HLVX N/A
- Industry
- ASYS Industrial Machinery/Components
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- HLVX Health Care
- Exchange
- ASYS Nasdaq
- HLVX Nasdaq
- Market Cap
- ASYS 70.3M
- HLVX 83.7M
- IPO Year
- ASYS N/A
- HLVX 2022
- Fundamental
- Price
- ASYS $3.95
- HLVX $1.97
- Analyst Decision
- ASYS
- HLVX Hold
- Analyst Count
- ASYS 0
- HLVX 5
- Target Price
- ASYS N/A
- HLVX $2.33
- AVG Volume (30 Days)
- ASYS 72.4K
- HLVX 294.9K
- Earning Date
- ASYS 05-12-2025
- HLVX 05-08-2025
- Dividend Yield
- ASYS N/A
- HLVX N/A
- EPS Growth
- ASYS N/A
- HLVX N/A
- EPS
- ASYS N/A
- HLVX N/A
- Revenue
- ASYS $90,826,000.00
- HLVX N/A
- Revenue This Year
- ASYS N/A
- HLVX N/A
- Revenue Next Year
- ASYS $31.66
- HLVX N/A
- P/E Ratio
- ASYS N/A
- HLVX N/A
- Revenue Growth
- ASYS N/A
- HLVX N/A
- 52 Week Low
- ASYS $3.20
- HLVX $1.34
- 52 Week High
- ASYS $6.96
- HLVX $16.31
- Technical
- Relative Strength Index (RSI)
- ASYS 42.14
- HLVX 65.41
- Support Level
- ASYS $3.26
- HLVX $1.84
- Resistance Level
- ASYS $3.59
- HLVX $1.93
- Average True Range (ATR)
- ASYS 0.18
- HLVX 0.09
- MACD
- ASYS 0.05
- HLVX 0.00
- Stochastic Oscillator
- ASYS 72.22
- HLVX 87.80
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.